Donald Trump is to continue his coronavirus treatment while in the White House

Donald Trump is to continue his coronavirus treatment while in the White House which includes a cocktail of drugs and a fifth and final treatment of remdesivir.

President Trump will continue to fight the virus and its symptoms while staying in the White House, as opposed to the Walter Reed hospital.

His doctors have said that his treatment is “top notch” and that the President will have medic readily available. On Friday he stared to receive oxygen for his shortness of breath and also began a course of remdesivir, an intravenous antiviral drug.

He will also continue to take the steroidal anti-inflammatory, dexamethasone. This is said to reduce pain and inflammation whilst increasing energy levels and general well-being.

He has also taken a one-off dose, eight grams, of an experimental drug regeneron, which is a lab-made artificial antibody designed to fight coronavirus. This treatment is already being trialled in four hospitals across the UK with it being expected to be rolled out to another 40 in the near future.


Thank you for taking the time to read this article “Donald Trump is to continue his coronavirus treatment while in the White House”. For more news from Home and Abroad, visit the Euro Weekly News homepage.

Euro Weekly News is delighted to continue be able to bring you a range of News that doesn’t cost you anything but your internet connection. Whether it’s Local Spanish News or International Entertainment News, we’ve got you covered!

FacebookTwitterRedditWhatsAppTelegramLinkedInEmailCopy Link
Go Back
Written by

Chris Kidd

Chris has spent a colourful and varied international career in the Arts followed by a substantial career in Education. Having moved to Spain in 2019 for a different pace and quality of life with his fiancé, he has now taken up a new and exciting role working with the online department of Euro Weekly News. Share your story with us by emailing [email protected], by calling +34 951 38 61 61 or by messaging our Facebook page www.facebook.com/EuroWeeklyNews

Comments


    Leave a comment

    Your email address will not be published.